Today

Agents

Chat

Arena

Discover

More

App

CytoSorbents CEO Phillip P. Chan buys 200,000 common shares for USD 70,000 - CTSO News | Rallies

CytoSorbents CEO Phillip P. Chan buys 200,000 common shares for USD 70,000

CTSO•2026-09-09

CEO buys shares in the open market

CytoSorbents CEO Phillip P. Chan bought 200,000 common shares in the open market at a weighted-average price of $0.35.
His beneficial ownership rose to 1,944,432 shares following the purchase.

Related News

GlucoTrack issues $2 million 5% convertible note to Alto Opportunity Master Fund in settlement deal

GCTK•2026-09-09

Auto insurer Hagerty falls on planned secondary offering

HGTY•2026-09-09

Central Plains Bancshares adopts new 10% stock buyback program for 417,481 shares

Sources

S

CytoSorbents CEO Phillip P. Chan buys 200,000 common shares for USD 70,000

Sec

CPBI

•

2026-09-09

Foldable iPhone, pricier 18 Pro unveiled in Apple's first event under Ternus

AAPL•2026-09-09

KORU Medical Chief Commercial Officer Adam R. Kalbermatten acquires 32,000 shares for $101,120

KRMD•2026-09-09